Endologix Comments On NEJM Study Highlighting Advantages Of Minimally Invasive Endovascular Repair
Endologix, Inc. (Nasdaq:ELGX), developer and manufacturer of the Powerlink(R) System endoluminal stent graft (ELG) for the minimally invasive treatment of abdominal aortic aneurysms (AAA), noted a study published in the January 31, 2008 New England Journal of Medicine comparing results of AAA repair following open surgery and endovascular repair.
More: continued here
Filed under: Blood on February 7th, 2008